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ABSTRACT  
Novel Polymerized Ionic Liquids (PILs)-based Hydrogels as Innovative Drug Delivery Systems are presented. The 
embedding of drugs in hydrogels enables the “smart” delivery of bioactive molecules from drugs for an oral route of 
administration. Therefore, a high mechanical strength as well as a favorable pH-dependent swelling behavior is required 
which is shown in this study. A mechanical compression of PILs-based hydrogels up to 98.5% and a high swelling 
behavior of poly(VEImBr) hydrogels in a solution with a high pH value is achieved. A significant lower swelling is 
achieved in a solution with a lower pH value. 
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INTRODUCTION 
Due to the growing demand for a controlled release of 
drugs in the pharmaceutical industry, there has been a 
considerable interest in the development of novel and 
reliable drug-delivery systems. Therefore, the literature 
considers various approaches, including the embedding 
of drugs in hydrogels. Such innovative systems enable 
the “smart” delivery of bioactive molecules from drugs. 
However, there are several disadvantages of already 
existing intelligent hydrogels, such as their low 
mechanical stability, limited and not completely 
reversible swelling capacity, and slow response to 
external stimuli. Due to the inadequate properties of 
these existing hydrogels our focus is on novel 
polymerized ionic liquids-based hydrogels as drug 
carriers for oral route of administration. The aim of this 
research is to achieve a selective drug release from 
hydrogels over a defined time period and at a specific 
location in order to control the duration of the action 
while minimizing undesired effects outside the site of 
action.  
RESEARCH CONCEPT 
In order to investigate the PILs-based hydrogels as 
innovative drug delivery systems, the dimensionally-
stable PILs are being obtained by radical 
polymerization. An imidazolium-based ionic liquid 
bearing a vinyl group is polymerized with the cross-
linker N,N’-methylenebisacrylamide. The embedding of 
a drug can be achieved by adding an active 
pharmaceutical ingredient (API) dissolved in water 
during the synthesis, as shown in Figure 2. As model 
substances simplified structures of protein kinase 
inhibitors are used. There are several variation 
possibilities during the synthesis, which have decisive 
effect on the synthesis of the 
hydrogel, e.g. content and type 
of cross-linker, water content 
and the ionic liquid. At the 
same time, however, the 
properties of the hydrogel is 
obviously also influenced by 
the variation. 
Figure 1. Synthesized
Hydrogels in a fresh
(left) and dried (right)
state. 
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Figure 2: Synthesis of PILs-based hydrogel poly(VEImBr); 
radical polymerization of [VEIm] [Br] – 1-Vinyl-3-
ethylimidazolium bromide and cross-linker N,N’-
methylenebisacrylamide. APS – Ammonium peroxydisulfate, 
TEMED – N,N,N’,N’-tetramethylethane-1,2-diamine, 1 – 7-
Halogenindol-3-carbonitrile.  
CHARACTERIZATION 
Mechanical Properties 
Due to their high water content hydrogels possess 
generally a weak mechanical strength. However, the 
advantage of PILs-based hydrogels over e.g. alginate-
based hydrogels is their significantly higher mechanical 
stability [Bandomir, 2014]. The mechanical properties 
are affected by the IL monomer, composition, cross-
linking density, degree of drying or swelling and drying 
method. A reversible compressibility (ε) of a fresh 
synthesized poly(VEImBr) hydrogel in physiological 
saline of up to 72% without crack formation is achieved. 
This compression behavior is increased by increasing 
the drying time in a climatic chamber.  
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Figure 3: Elongation tests of poly(VEImBr) and 
poly(ViPrImBr) hydrogels with different degrees of drying at 
25 °C and 60% RH partially in 0.9% NaCl solution with a 
loading speed of 0.1%/s. 
With increased drying time, the reversible compression 
without crack formation increased already up to 98.5% 
in the air and up to 88.9% in physiological saline for 
poly(VEImBr), for poly(ViPrImBr) up to 87.4%, as 
shown in Figure 3. 
Swelling behavior 
The swelling property of hydrogels is a significant factor 
for controlled drug releases [Rizwan, 2017]. Drug 
release generally involves the simultaneous absorption 
of water and desorption of a drug via a swelling-
controlled diffusion mechanism. The produced 
hydrogels show a pH-dependent swelling behavior, as 
shown in Figure 4Fehler! Verweisquelle konnte nicht 
gefunden werden.. Due to the large variations of pH-
values at various body sites, the swelling and thus the 
release of the API will only take place at the desired site 
of action in the body. By further functionalization of the 
PILs, the swelling behavior of the hydrogels as well as 
the drug release can be affected crucial. 
0 2 4 6 8 10 12 14 16 18 20 22
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
5.5
6.0
V
ol
um
e 
[c
m
3 ]
Time [h]
 pH 5
 pH 4
 pH 3
 pH 2
 pH 1
Figure 4: Swelling trend of fresh poly(VEImBr) hydrogels in 
0.9% NaCl solution with different pH-values. 
Drug release behavior 
Initial findings on the drug release behavior can be 
adapted from catalyst-leaching experiments 
[Großeheilmann, 2015]. Leaching behavior with 
different drying methods, catalyst structures, water 
content, and solvents was investigated. Due to these 
experiments, drug release mechanisms can be 
influenced by various parameters, such as drying 
methods, crosslinker-to-IL ratio, IL monomer, solvent / 
pH of the aqueous medium, drug size, and drug polarity. 
The first studies on drug release behavior of model 
substances are currently under investigation. As model 
substances simplified structures of protein kinase 
inhibitors, which are used in the development of drugs 
for Down syndrome and Alzheimer’s disease, are used.  
Biocompatibility 
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Initial experiments show that most of the IL monomers 
are toxic before polymerization, except monomers with 
an isopropyl group. Fortunately, the PILs-based 
hydrogels show low to no toxicity after polymerization. 
Further biocompatibility tests are currently under 
investigation. In addition, the change from a batch 
process to a continuous process for washing out 
unreacted IL monomer from the PILs is currently being 
developed to obtain biocompatible PILs-based 
hydrogels. 
CONCLUSIONS 
Stable PILs-based hydrogels were successfully 
synthesized by a radical polymerization. The 
mechanical stability of these hydrogels is shown by a 
reversible compression up to 90% without crack 
formation. Initial findings show low to no toxicity after 
polymerization. Drug release can be controlled by pH-
dependent swelling behavior. In future, an increased pH-
responsive drug release should be obtained by 
functionalizing the PILs. 
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NOMENCLATURE 
API Active Pharmaceutical Ingredient 
APS Ammonium peroxydisulfate 
IL Ionic Liquid 
PILs Polymerized Ionic Liquids 
RH Relative Humidity 
TEMED N,N,N’,N’-Tetramethylethane-1,2-
diamine 
VEImBr  1-Vinyl-3-ethylimidazolium bromide
ViPrImBr 1-Vinyl-3-isopropylimidazolium
bromide
ε Compressibility 
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